New patent expiration for Padagis Us drug CLINDESSE – DrugPatentWatch
Annual Drug Patent Expiration for CLINDESSE
Clindesse is a drug marketed by Padagis Us and included in one NDA. It is available from a single supplier. There are two patents protecting this drug and one Paragraph IV challenge.
CLINDESSE drug price trends.
Drug patent litigation for CLINDESSE.
This drug has forty-four patent family members in twenty-one countries.
The generic ingredient in CLINDESSE is clindamycin phosphate. One registered supplier for this compound. Additional details are available on the clindamycin phosphate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Make Better Decisions with DrugPatentWatch
» Start Your Free Trial Today «
Copyright © DrugPatentWatch. Originally published in Recently expired patent for CLINDESSE’s drug Padagis Us